BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
latest_posts
- 1
People who talk with their hands seem more clear and persuasive – new research - 2The Best Computer games Ever
- 3Astronomer captures 2 meteors slamming into the moon (video)
- 410 Hints for a Fruitful New employee screening
- 5Toddler diagnosed with cancer makes remarkable recovery after aggressive treatment
- Step by step instructions to Guarantee Your Internet Promoting Degree Supplements Your Profession Objectives
- No injuries after blast at pro-Israel centre in the Netherlands
- The Following Huge Thing: 5 Progressive Tech New businesses
- NASA is sending astronauts back to the moon. Can you see the Artemis 4 landing sites from Earth?
- Dave Coulier reveals he has tongue cancer, his 2nd diagnosis in a year, after beating non-Hodgkin lymphoma
- Canada's Friendly Sunshine Coast City Is An Outdoor Playground Perfect For Hiking And Paddling
- Sought-After Extravagance Ocean side Objections for a Lovely Escape
- More than 3 million eye drops have been recalled from CVS, Walgreens and other national retailers. How to check if yours are safe
- Aid sent by ambulance to Ukraine front line
